"It is a great pleasure for me working with Bentham Science Publication. Bentham Science Publication “Infectious Disorders – Drug Targets” is one of the best publishers in many fields such as medicinal chemistry , pharmacology…etc, that always aim to develop the pharmaceutical industries."
Hourieh Alkadi (Faculty of Pharmacy, Arab International University, Syrian Arab Republic)
"This letter shows my gratitude to Bentham Science Publisher. Bentham Science Publisher is one of the global leading publishers in the field of pharmaceutical science. It publishes a large variety of international journals serving different ranges of authors and readers. I have vast and pleasurable experience with some leading journals of BSP. I hope more authors and readers will participate and learn from this platform in the future."
Da Yong Lu (School of Life Sciences, Shanghai University, Shanghai 200444, China)
"It is a pleasure for me to write few words on my experience of working with Bentham Science Publishers. My manuscripts published in Infectious Disorders Drug Targets found a high impact in the scientific community working on AIDS similar to high ranked journals where we used to publish our work. I am sending now our best manuscrips to this journal and I know that Infectious Disorders should becoming soon a reference in AIDS research."
Erwann Loret (Director ERT 2011 Faculty of Pharmacy 27 Bd Jean Moulin 13385 Marseille France , )
"It was a fulfilling experience working with Bentham Science Publication “Infectious Disorders – Drug Targets,” Right from the submission to the proof reading of the article, all of the employees of Bentham Science Publication “Infectious Disorders – Drug Targets,” are genuinely kind, concerned, competent and hearing to the issues raised by the authors.
I would like to say that I am very much interested to work with Bentham Science Publication in future. I am also interested to write scientific review articles and short communications on dental subjects, and a few related medical subjects.
Dr Vagish Kumar L S
Jean-Marc Sabatier Laboratoire ERT 62 'Ingénierie des peptides à visée thérapeutique' Université de la Méditerranée Faculté de Médecine Nord Boulevard Pierre Dramard 13916 - MARSEILLE, Cedex 20 (France)
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.